ADC Therapeutics S.A.ADCTNYSE
LOADING
|||
Switch Symbol:
R&D Expense Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-13.76%
↓ 375% below average
Average (8y)
5.00%
Historical baseline
Range
High:38.33%
Low:-31.82%
Volatility
1403.9%
High variability
| Period | Value |
|---|---|
| 2024 | -13.76% |
| 2023 | -31.82% |
| 2022 | 18.01% |
| 2021 | 11.24% |
| 2020 | 32.08% |
| 2019 | -9.11% |
| 2018 | 38.33% |
| 2017 | 0.00% |
| 2016 | 0.00% |